Instrument overview

ADAPAdaptimmune Therapeutics

StockStockUnited StatesHealth careEU retail investors: available

0.0% today · −50.0% over a year

No score: too little data.

No dividend.

Over the past 12 months the price changed by −50.0%, with an annualised volatility of 231% and a largest fall of 83%.

Not scored: not enough data for a fair comparison.

Red flags and notes

  • Caution. Median daily trading below €100,000: wider spreads and harder exits. More in the glossary → Median daily trading below €100,000: wider spreads and harder exits.
  • Below $1 Price below one US dollar: not ranked against peers.

Price chart

Interactive chart by TradingView: exchange prices are delayed, crypto and currencies are live.

No interactive chart is available for this listing.

Key metrics

Dividends

Dividend yield
0.00%
Years without a lower dividend
0

Returns and risk

1 day
0.0%
1 month
−33.3%
1 year
−50.0%
Volatility, 1 yr
231.1%
Max drawdown, 1 yr
−83.3%
Beta
−1.11

Returns are price changes from end-of-day prices, without dividends.

Similar companies

Same sector, closest in price swings over the past year.

GOSSGossamer Bio Inc—/100.0%−94.7%
REPLReplimune Group Inc.1/100.0%154.4%
KRSAKorsana Biosciences Inc.—/100.0%162.5%
AGLagilon health inc.1/100.0%550.7%
ATRAAtara Biotherapeutics Inc—/100.0%−33.4%
KODKodiak Sciences Inc1/100.0%487.6%
MRNAModerna Inc2/100.0%944.8%
ZNTLZentalis Pharmaceuticals—/100.0%32.3%

News and filings

No recent news or filings in our sources.

Score changes in the last 12 months

Every published rating and change, logged when it was published (EU Market Abuse Regulation).

Show the log: 1 entry
DateEventBalancedGrowth · IncomeWarningsPrice at publication
First rating —/10 — · — Available with Invest Pro

Ratings are rules-based descriptions, valid until the next scoring run (about 06:20 and 21:50 UTC) and the same for every visitor.